| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
5 FluorouracilDNA (Repair and Toxicology)| 1 | 1999 | 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. | 
| + | - | nl | Cancer 86(7):1129-34 (1999) Fata F |
| 2 | 1999 | Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance. |
| + | - | nl | Clin Cancer Res 5(10):2672-3 (1999) |
| 3 | 1999 | Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil? |
| + | - | nl | Clin Cancer Res 5(8):1947-9 (1999) |
| 4 | 2001 | From 5 fluorouracil to the new oral fluoropyrimidines: a brief overview of four decades of clinical investigations. |
| + | - | nl | Isr Med Assoc J 3(4):278-81 (2001) |
| 5 | 2009 | Participation of DNA repair in the response to 5-fluorouracil. |
| + | - | nl | Cell Mol Life Sci 66(5):788-99 (2009) |
| 6 | 2008 | Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? |
| + | - | nl | Clin Cancer Res 14(1):8-13 (2008) |
